Pre-vaccination monocyte-to-lymphocyte ratio as a biomarker for the efficacy of malaria candidate vaccines: A subgroup analysis of pooled clinical trial data.

Nyandele, Jane Paula; Kibondo, Ummi Abdul; Issa, Fatuma; Van Geertruyden, Jean Pierre; Warimwe, George; Jongo, Said; Abdulla, Salim; Olotu, Ally

Nyandele, Jane Paula; Kibondo, Ummi Abdul; Issa, Fatuma; Van Geertruyden, Jean Pierre; Warimwe, George; Jongo, Said; Abdulla, Salim; Olotu, Ally.

Afiliação

Nyandele JP; Global Health Institute, University of Antwerp, Antwerp, Belgium.
Kibondo UA; Ifakara Health Institute, Bagamoyo Clinical Trial Unit, Bagamoyo, Tanzania.
Issa F; Ifakara Health Institute, Bagamoyo Clinical Trial Unit, Bagamoyo, Tanzania.
Van Geertruyden JP; Ifakara Health Institute, Bagamoyo Clinical Trial Unit, Bagamoyo, Tanzania.
Warimwe G; Global Health Institute, University of Antwerp, Antwerp, Belgium.
Jongo S; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Abdulla S; Ifakara Health Institute, Bagamoyo Clinical Trial Unit, Bagamoyo, Tanzania.
Olotu A; Ifakara Health Institute, Bagamoyo Clinical Trial Unit, Bagamoyo, Tanzania.

PLoS One ; 18(9): e0291244, 2023.

Article em En | MEDLINE | ID: mdl-37708143

Assuntos

Vacinas Antimaláricas; Humanos; Animais; Vacinas Antimaláricas/uso terapêutico; Monócitos; Biomarcadores; Linfócitos; Esporozoítos; Vacinação

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Antimaláricas Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google